Conference
Index | Round
Tables | Selected
Abstracts | News
Summaries
21 July
ApoE in Alzheimer's Disease and Neurodegeneration:
Diagnostic and Therapeutic Opportunities. Chairperson:
Mahley, R.W. (San Fransisco, CA, US), Lannfelt, L. (Huddinge,
Sweden). Sponsored by an educational grant from Glaxo
Wellcome
Animal Model Studies of the Role of Apolipoprotein
E in Neuronal Maintenance and Repair. Michaelson,
D. (Tel Aviv, ISRAEL)
Listen
to RealAudio
ApoE Isoforms and Neurite Outgrowth: Possible Role
of Heparan Sulfate Proteoglycans. Pitas, R.; Ji, Z.;
Fuki, I.; Williams, K.; Mahley, R. (San Francisco,
CA, US)
Listen
to RealAudio
ApoE: Isoform Specific Antioxidant Activity. Smith,
J.; Sikes, J.; Perry, G.; Smith, M. (New York, NY,
US)
Listen
to RealAudio
Apolipoprotein E Modulates Microglial Activation.
Laskowitz, D.; Mcmillian, M.; Roses, A. (Durham, NC,
US)
Listen
to RealAudio
Apolipoprotein E: a Potential Therapeutic Target
to Alleviate Cholinergic Dysfunction and b Amyloid
Deposition in Alzheimer's Disease. Poirier, J.; Danik,
M.; Ramassamy, C.; Kryskovsky, P.; Beffert, U. (Montreal,
CANADA)
Listen
to RealAudio
ApoE Genotype and Clinical and Pathological Correlation.
Soininen, H.; Lehtovirta, M.; Helisalmi, S.; Alafuzoff,
I.; Riekkinen Sr, P. (Kuopio, FINLAND)
Listen
to RealAudio
|